Sam Matthews, MSc

AstraZeneca, United Kingdom

Disclosure(s): Exploristics Ltd. (contracted to AstraZeneca): Employee of Exploristics Ltd.

Poster(s):

• (P-1969) Safety, Immunogenicity, and Pharmacokinetics of Repeat Dosing with AZD7442 (Tixagevimab/Cilgavimab): Final Analysis of the ENDURE Phase 2, Dose-Ranging Study in Immunocompromised Participants
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT